启迪药业：控股股东湖南赛乐仙累计质押股数约4396万股

Core Viewpoint - Tsinghua Unigroup (启迪药业) announced that its controlling shareholder, Hunan Sailoxian Management Consulting Partnership, has pledged a portion of its shares for financing guarantees, with 43.96 million shares pledged, accounting for 75% of its holdings [1] Financial Performance - For the first half of 2025, Tsinghua Unigroup's revenue composition was as follows: Traditional Chinese medicine and health products accounted for 94.02%, while other products made up 5.98% [1] - The current market capitalization of Tsinghua Unigroup is 3 billion yuan [1]